GlassScriptPhysician profile
Lyle D Pahnke
NPI 1770538225
$94.25
in general payments reported to CMS, 2019-2025
5 companies · $38.87 in 2025
The $38.87 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.60 · 2022: $11.66 · 2023: $14.27 · 2024: $11.85 · 2025: $38.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $26.80 | 2022-2025 | Tcc-Ez |
| Solventum Corporation | $23.73 | 2025 | Snap |
| Takeda Pharmaceuticals U.S.A., INC. | $17.60 | 2019 | |
| Molnlycke Health Care US, LLC | $14.27 | 2023 | Mepilex Border Sacrum, Mepitel Ag, Exufiber Ag+ |
| Cashflow Solutions, LLC | $11.85 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyle Pahnke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.